Dr. Reddy's launches generic Alzheimer's drug
NEW YORK — Dr. Reddy's Labs has launched a drug for treating Alzheimer's disease, the company said.
Dr. Reddy's announced the launch of rivastigmine tartrate capsules in the 1.5-mg, 3-mg, 4.5-mg and 6-mg strengths.
The drug is a generic version of Novartis' Exelon. Exelon and other generic versions of the drug had sales of about $92.6 million during the 12-month period ended in June, according to IMS Health.